Sameh Syed, MD
Pulmonary Disease · Mobile, ALNPI 1336643469
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,637, more than ten times the $16 reported in 2019. That places this record below the midpoint for pulmonary disease clinicians in AL, where the typical reported total is $3,082.
Across 119 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$679
- AstraZeneca$331
- United Therapeutics Corporation$262
- Actelion Pharmaceuticals US, Inc.$222
- Pulmonx Corporation$214
- Merck$179
- plus $1K from 13 others
What the payments were for
- Food & beverage$2,87297%
- Education$793%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 35 | $679 |
| AstraZeneca | 15 | $331 |
| United Therapeutics Corporation | 7 | $262 |
| Actelion Pharmaceuticals US, Inc. | 7 | $222 |
| Pulmonx Corporation | 2 | $214 |
| Merck | 8 | $179 |
| Mallinckrodt Hospital Products Inc. | 3 | $167 |
| Sanofi | 3 | $159 |
| Regeneron Healthcare Solutions, Inc. | 10 | $147 |
| Boehringer Ingelheim | 2 | $95 |
| Vifor Pharma, Inc. | 4 | $93 |
| Jazz Pharmaceuticals Inc. | 4 | $88 |
| Amgen | 3 | $80 |
| Electromed, Inc. | 8 | $70 |
| Viatris Specialty LLC | 3 | $57 |
| La Jolla Pharmaceutical Company | 2 | $53 |
| Verona Pharma, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Fresenius USA Marketing, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$238
- CHARTIS CATHETER$125
- ZEPHYR ENDOBRONCHIAL VALVE$125
- PULMONX CHARTIS TABLET CONSOLE$125
- ZEPHYR DELIVERY CATHETER$125
- AREXVY$122
- NUCALA$120
- ACTHAR$107
- TYVASO$101
How this compares
$2,951 in reported general payments places this provider in the 45th percentile of 215 pulmonary disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,107 |
| Prednisone | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Mobile
- Adrian DivittorioMobile$100K
- Peter LutzMobile$63K
- Virginia RadcliffMobile$23K
- Johnson HaynesMobile$21K
- Cynthia CrowderMobile$20K
- Philip AlmaloufMobile$14K
- Campbell SindelMobile$14K
- Chibuzo OdigweMobile$14K
- Caesar AgaganMobile$11K
- James DeanMobile$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.